BSEM insider filings

BioStem Technologies, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen BSEM transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 17 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Matuszewski Jason — Chief Executive Officer, Director, 10% owner3—1 leg · 14,300 sh · $14,3006
SMITH-VAN VURST ANDREW — Chief Operating Officer, Director, 10% owner2——6
FORTUNATO MICHAEL A — Chief Accounting Officer2——4
HASSETT BARRY — Chief Commercial Officer2——4
POE BRANDON — Chief Financial Officer2——4
WARRINGTON KENNETH HOWARD JR — Director2——4
Glickman Mark A — Director1——2
LESSER HANNAWAY RAYNA — Director1——2
SONENREICH STEVEN D — Director1——2
UNGRODT JODI — Director1——2

Recent insider filings — BioStem Technologies, Inc.

FiledFormInsiderReported transactionsSource
2026-11-194Matuszewski Jason — Chief Executive Officer, Director, 10% ownerSale (S): 14,300 @ $1EDGAR
2026-11-134POE BRANDON — Chief Financial OfficerOption exercise (M): 2,699 @ $0 · Option exercise (M): 2,699 (derivative) @ $0EDGAR
2026-11-104FORTUNATO MICHAEL A — Chief Accounting OfficerOption exercise (M): 970 @ $0 · Option exercise (M): 970 (derivative) @ $0EDGAR
2026-11-034HASSETT BARRY — Chief Commercial OfficerOption exercise (M): 253 @ $0 · Option exercise (M): 253 (derivative) @ $0EDGAR
2026-10-094Matuszewski Jason — Chief Executive Officer, Director, 10% ownerOption exercise (M): 250,000 @ $2 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2026-10-094SMITH-VAN VURST ANDREW — Chief Operating Officer, Director, 10% ownerOption exercise (M): 250,000 @ $2 · Option exercise (M): 250,000 (derivative) @ $0EDGAR
2026-09-174FORTUNATO MICHAEL A — Chief Accounting OfficerOption exercise (M): 4,234 @ $0 · Option exercise (M): 4,234 (derivative) @ $0EDGAR
2026-09-174WARRINGTON KENNETH HOWARD JR — DirectorOption exercise (M): 1,694 @ $0 · Option exercise (M): 1,694 (derivative) @ $0EDGAR
2026-09-174Matuszewski Jason — Chief Executive Officer, Director, 10% ownerOption exercise (M): 8,469 @ $0 · Option exercise (M): 16,650 @ $0 · Option exercise (M): 8,469 (derivative) @ $0 · Option exercise (M): 16,650 (derivative) @ $0EDGAR
2026-09-174SMITH-VAN VURST ANDREW — Chief Operating Officer, Director, 10% ownerOption exercise (M): 7,622 @ $0 · Option exercise (M): 9,574 @ $0 · Option exercise (M): 7,622 (derivative) @ $0 · Option exercise (M): 9,574 (derivative) @ $0EDGAR
2026-09-174POE BRANDON — Chief Financial OfficerOption exercise (M): 1,694 @ $0 · Option exercise (M): 1,694 (derivative) @ $0EDGAR
2026-09-114HASSETT BARRY — Chief Commercial OfficerOption exercise (M): 500 @ $0 · Option exercise (M): 500 (derivative) @ $0EDGAR
2026-08-284SONENREICH STEVEN D — DirectorOption exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0EDGAR
2026-08-284WARRINGTON KENNETH HOWARD JR — DirectorOption exercise (M): 5,094 @ $0 · Option exercise (M): 5,094 (derivative) @ $0EDGAR
2026-08-284Glickman Mark A — DirectorOption exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0EDGAR
2026-08-284LESSER HANNAWAY RAYNA — DirectorOption exercise (M): 7,671 @ $0 · Option exercise (M): 7,671 (derivative) @ $0EDGAR
2026-08-284UNGRODT JODI — DirectorOption exercise (M): 5,647 @ $0 · Option exercise (M): 5,647 (derivative) @ $0EDGAR
2026-08-204FORTUNATO MICHAEL A — Chief Accounting OfficerOption exercise (M): 970 @ $0 · Option exercise (M): 970 (derivative) @ $0EDGAR
2026-08-204POE BRANDON — Chief Financial OfficerOption exercise (M): 10,634 @ $0 · Option exercise (M): 10,634 (derivative) @ $0EDGAR

Recent 8-K events — BioStem Technologies, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-308-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-188-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-078-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — BioStem Technologies, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=BSEM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs